RIT was furthermore a highly significant independent favorable prognostic factor with regard to recurrence-free survival in stage I patients, although not in stage II and III patients.
← all excerpts
Differentiated thyroid cancer patients potentially benefitting from postoperative I-131 therapy: a review of the literature of the past decade.
1
—
—